{"id":"W4387026351","doi":"10.1016/j.jaad.2023.07.741","title":"42766 JAK of All Trades: Novel Off-Label Use of the Systemic JAK Inhibitor Upadacitinib As An Adjunct to Systemic Biologic Therapy for Various Immune-Mediated Inflammatory Diseases of the Skin","year":2023,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary; University of Alberta; SKiN Health; Western University","funders":"Eli Lilly and Company","keywords":"Medicine; Adalimumab; Secukinumab; Infliximab; Etanercept; Dermatology; Psoriasis; Ustekinumab; Adverse effect; Janus kinase; Atopic dermatitis; Systemic therapy; Internal medicine; Immunology; Psoriatic arthritis; Disease; Tumor necrosis factor alpha; Cytokine; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002136204,0.0002888096,0.0005555395,0.0003105471,0.0003369708,0.0006909526,0.0002898307,0.0005894554,0.006956314],"category_scores_gemma":[0.0002041442,0.00009687409,0.0004563489,0.0001970131,0.0002611435,0.0003553909,0.0002731648,0.001231476,0.001349524],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003498261,"about_ca_system_score_gemma":0.0003152971,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003639407,"about_ca_topic_score_gemma":0.001781251,"domain_scores_codex":[0.9998916,0.00001753619,0.000007445284,0.00002166768,0.00002775809,0.00003400905],"domain_scores_gemma":[0.9999318,0.00001359257,0.00001164311,0.000006054845,0.00000794611,0.00002886633],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"case_report","study_design_scores_codex":[0.01322138,0.00235971,0.004465352,0.0009000394,0.0003077197,0.00630534,0.0001160938,0.0007935084,0.111172,0.003352022,0.03375036,0.8232566],"study_design_scores_gemma":[0.02176624,0.04186482,0.04874906,0.0008859268,0.001888147,0.08830861,0.0002951998,0.01213681,0.1643685,0.003620945,0.6158308,0.0002849349],"study_design_candidate":"case_report","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8127309,0.07165783,0.005994856,0.008354111,0.002887559,0.0005705194,0.001704062,0.0009679157,0.09513219],"genre_scores_gemma":[0.972665,0.009103006,0.002352478,0.002241121,0.0005452994,0.00009445677,0.0007635258,0.00004625591,0.01218882],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006956314,"threshold_uncertainty_score":0.02327114,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03504583361941069,"score_gpt":0.3150777716178583,"score_spread":0.2800319379984476,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}